Advertisement
Screener

CALLISTO PHARMACEUTICALS INC Stock-Based Compensation

CALLISTO PHARMACEUTICALS INC Stock-Based Compensation

CALLISTO PHARMACEUTICALS INC reported Stock-Based Compensation of $21.60 million for the 196-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2012-11-19

  • CALLISTO PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $15.11K, a 85.62% decline year-over-year.
  • CALLISTO PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $124.28K, a 63.95% decline year-over-year.
  • CALLISTO PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $525.92K, a 321.91% increase year-over-year.
  • CALLISTO PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $648.92K, a 167.26% increase year-over-year.
  • CALLISTO PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $1.22M, a 43.15% increase from fiscal 2010.
  • CALLISTO PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $854.65K, a 23.68% decline from fiscal 2009.
  • CALLISTO PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2009 was $1.12M.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 181 monthShare-based Payment Arrangement, Noncash Expense 184 monthShare-based Payment Arrangement, Noncash Expense 187 monthShare-based Payment Arrangement, Noncash Expense 190 monthShare-based Payment Arrangement, Noncash Expense 193 monthShare-based Payment Arrangement, Noncash Expense 196 month
2012-09-30$15.11K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19
$139.40K
derived: sum of 2 quarters · filed 2012-11-19
$665.32K
10-Q · filed 2012-11-19
$1.31M
derived: sum of 4 quarters · filed 2012-11-19
$21.60M
10-Q · filed 2012-11-19
2012-06-30$124.28K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28
$650.20K
10-Q/A · filed 2012-08-28
$1.30M
derived: sum of 3 quarters · filed 2012-08-28
$1.40M
derived: sum of 4 quarters · filed 2012-11-19
$21.58M
10-Q/A · filed 2012-08-28
2012-03-31$525.92K
10-Q · filed 2012-05-15
$1.17M
derived: sum of 2 quarters · filed 2012-05-15
$1.28M
derived: sum of 3 quarters · filed 2012-11-19
$1.62M
derived: sum of 4 quarters · filed 2012-11-19
$21.46M
10-Q · filed 2012-05-15
2011-12-31$648.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$754.02K
derived: sum of 2 quarters · filed 2012-11-19
$1.10M
derived: sum of 3 quarters · filed 2012-11-19
$1.22M
10-K · filed 2012-03-30
$20.93M
10-K · filed 2012-03-30
2011-09-30$105.10K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19
$449.89K
derived: sum of 2 quarters · filed 2012-11-19
$574.54K
10-Q · filed 2012-11-19
$817.35K
derived: sum of 4 quarters · filed 2012-11-19
$20.28M
10-Q · filed 2011-11-14
2011-06-30$344.79K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28
$469.44K
10-Q/A · filed 2012-08-28
$712.25K
derived: sum of 3 quarters · filed 2012-08-28
$874.14K
derived: sum of 4 quarters · filed 2012-08-28
$20.18M
10-Q · filed 2011-08-15
2011-03-31$124.65K
10-Q · filed 2012-05-15
$367.46K
derived: sum of 2 quarters · filed 2012-05-15
$529.35K
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$242.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$404.70K
derived: sum of 2 quarters · filed 2012-03-30
$854.65K
10-K · filed 2012-03-30
2010-09-30$161.89K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$611.85K
10-Q · filed 2011-11-14
2010-06-30$449.95K
10-Q · filed 2011-08-15
2009-12-31$1.12M
10-K · filed 2012-03-30